— Know what they know.
Not Investment Advice

SDSS OTC

Suspect Detection Systems Inc.
1W: +0.0% 1M: +0.0% 3M: +0.0% YTD: +0.0% 1Y: +0.0% 3Y: -0.0% 5Y: -91.7%
$0.00
+0.00 (+0.00%)
 
OTC · Industrials · Aerospace & Defense · Tech Score Neutral · Power 50 · $7970 mcap · 79M float · 0.0022% daily turnover

Balance Sheet Trends

Total Assets
$234K -31.7% ▼
5Y CAGR: -30.9%
Total Liabilities
$3M +7.4% ▲
5Y CAGR: +161.2%
Shareholders Equity
-$2M -17.0% ▼
Cash & Investments
$152K -25.2% ▼
5Y CAGR: -3.3%
Total Debt
$619K +9.3% ▲
Net Debt
$467K +28.5% ▲

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2009FY2010FY2012FY2013FY2014
— Assets —
Cash$702K$803K$195K$203K$152K
Short-Term Investments$0$0$161K$0$0
Cash & ST Investments$702K$803K$356K$203K$152K
Net Receivables$0$288K$71K$0$0
Inventory$55K$188K$51K$52K$46K
Other Current Assets$16K$116K$0$35K$22K
Total Current Assets$838K$2M$478K$290K$220K
Property, Plant & Equip.$12K$31K$22K$17K$14K
Goodwill & Intangibles$1M$1M$0$0$0
Long-Term Investments$46K$90K$0$0$0
Other Non-Current Assets$11K$7K$33K$35K$0
Total Non-Current Assets$1M$1M$55K$53K$14K
Total Assets$2M$3M$533K$343K$234K
— Liabilities —
Accounts Payable$9K$43K$29K$0$1K
Short-Term Debt$0$0$0$0$0
Deferred Revenue$56K$113K$16K$119K$0
Other Current Liabilities$919K$2M$1M$2M$2M
Total Current Liabilities$1M$2M$1M$2M$2M
Long-Term Debt$0$0$514K$567K$619K
Other Non-Current Liab.$84K$89K$33K$35K$0
Total Non-Current Liabilities$84K$89K$547K$602K$619K
Total Liabilities$1M$2M$2M$2M$3M
— Equity —
Common Stock$7K$8K$10K$10K$10K
Retained Earnings-$2M-$3M-$8M-$8M-$9M
Accumulated OCI$0$0$0$0$0
Total Stockholders Equity$833K$623K-$1M-$2M-$2M
Total Liabilities & Equity$2M$3M$533K$343K$234K
— Key Metrics —
Total Debt$0$0$514K$567K$619K
Net Debt-$702K-$803K$319K$364K$467K
Total Investments$46K$90K$161K$0$0

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms